[REVISION HISTORY]
Iran Food and Drug Organization regulatory updates
8 recorded revisions of this situation.
What changed
2026-11-02 13:19 UTC → 2026-11-04 08:24 UTC ·
added
removed
The Food and Drug Organization of Iran continues to manage regulatory and supply chain challenges across medical, food, and cosmetic sectors. Regarding pharmaceutical logistics, Mehdi Pirsalahi reported that raw material transport costs have increased six to ten times due to shifts from air to rail and road transport, though domestic manufacturers remain at maximum capacity. While the supply of Factor XIII has been resolved, shortages of tricyclic antidepressants have been linked to transport restrictions from India. Recent reports from developments highlight a worsening psychiatric medication crisis. Seyyed Vahid Shariat, President of the Iranian Psychiatric Association, indicate warned that shortages and rising costs are forcing patients to reduce dosages or discontinue treatment, potentially leading to a significant surge in disease relapse and increased hospitalizations. Shariat noted that certain injectable psychiatric drugs are nearly impossible to find, which may strain a healthcare system already facing a shortage of psychiatric medications. beds. This crisis primarily affects domestically produced drugs due economic pressure may also lead patients to a dependence on imported raw materials. Reported shortages include antidepressants such as venlafaxine, duloxetine, sertraline, and mirtazapine, as well as long-acting antipsychotics, anti-anxiety medications like buspirone, delay medical visits, increasing risks of substance and clomipramine, which lacks a direct substitute for certain patients. alcohol abuse. In consumer safety, the agency has implemented strict controls on infant formula and issued warnings against immediate recall orders for FAT FAST tablets and Hemostasis powder. The FDA cited serious side effects and unauthorized sports supplements. Shahram Shoaybi, Director General of Natural, Traditional, therapeutic claims for FAT FAST, while Hemostasis powder, produced by Aria Teb Nik Seresht Toos, was recalled for lacking valid permits, authenticity labeling, and Supplement Products, warned that supplements sold through unofficial channels, such as social media or gyms, may contain dangerous substances like anabolic steroids or illegal stimulants. To ensure safety, officials urge for the fraudulent use of licensed pharmacies and the T-Tick tracking system. another company’s name as its manufacturing site. In the cosmetic sector, Behrouz Akbari, Deputy of the Cosmetic and Hygiene Products Directorate, noted the technical complexities of verifying halal status. This process requires assessing the chemical and biological origins of ingredients, such as collagen or snail extracts, and analyzing alcohol types in products like mouthwash to ensure compliance with religious and technical standards. Expanding on the Halal sector, this, Mehdi Pirsalehi, head of the Food and Drug Administration, Pirsalehi stated during the International Halal and Health Conference that the Halal concept now encompasses pharmaceuticals, medical equipment, dietary supplements, cosmetics, tourism, and healthcare services.
Versions
- 2026-11-04 08:24 UTC Iran Food and Drug Organization regulatory updates
- 2026-11-02 13:19 UTC Iran Food and Drug Organization regulatory updates
- 2026-11-01 11:13 UTC Iran Food and Drug Organization regulatory updates
- 2026-10-26 20:42 UTC Iran Food and Drug Organization regulatory updates
- 2026-10-20 12:53 UTC Iran Food and Drug Organization regulatory updates
- 2026-10-20 11:45 UTC Iran Food and Drug Organization regulatory updates
- 2026-09-27 06:45 UTC Iran Food and Drug Organization regulatory updates
- 2026-09-22 08:33 UTC Iran Food and Drug Organization regulatory updates
- 2026-09-20 12:56 UTC Iran Food and Drug Organization regulatory updates
Select a version to see what changed compared to the one before it.